共 50 条
- [1] Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study ANTIBIOTICS-BASEL, 2020, 9 (10): : 1 - 11
- [5] Meta-analysis of Clinical Outcomes Using Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam for the Treatment of Multidrug-Resistant Gram-Negative Infections OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (02):
- [6] Treatment of Multi-Drug Resistant Gram-Negative Bacterial Pathogenic Infections JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2020, 14 (03): : 1639 - 1647
- [7] Clinical outcomes of intensive care unit patients infected with multidrug-resistant gram-negative bacteria treated with ceftazidime/avibactam and ceftolozane/tazobactam Brazilian Journal of Microbiology, 2024, 55 : 333 - 341
- [9] Antimicrobial susceptibility of multi-drug and extensively-drug-resistant Escherichia coli to ceftolozane-tazobactam and ceftazidime-avibactam: An in vitro study POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2020, 74 : 77 - 83
- [10] Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria ISTANBUL JOURNAL OF PHARMACY, 2023, 53 (01): : 45 - 50